Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Riluzole, an SLC7A11-targeted drug identified in both datasets, is a glutamate antagonist that has been used to treat amyotrophic lateral sclerosis[25, 26]
Supplied as a solid research material, SLU-PP-332 is intended exclusively for controlled in-vitro laboratory research conducted by qualified professionals
Those procedures are coded using specialized infusion and injection codes (e.g., 9640196549)
However it should be highlighted that when CO23RFK is treated with MCFG there was not an increase in GSSG as it usually happens when different strains are treated with this drug
Shipping & Store Notes
US$ 29.00
US$ 26.60
US$ 26.84
